Adjuvant Radioactive Therapy after Reoperation for Locoregionally Recurrent Papillary Thyroid Cancer in Patients Who Initially Underwent Total Thyroidectomy and High-Dose Remnant Ablation | Zendy

Ji Hye Yim | Zendy; Won Bae Kim | Zendy; Eui Young Kim | Zendy; Won Gu Kim | Zendy; Tae Yong Kim | Zendy; JinSook Ryu | Zendy; Dae Hyuk Moon | Zendy; TaeYon Sung | Zendy; Jong Ho Yoon | Zendy; Seong Chul Kim | Zendy; Suck Joon Hong | Zendy; Young Kee Shong | Zendy

Open Access

Adjuvant Radioactive Therapy after Reoperation for Locoregionally Recurrent Papillary Thyroid Cancer in Patients Who Initially Underwent Total Thyroidectomy and High-Dose Remnant Ablation

Author(s) -

Ji Hye Yim,

Won Bae Kim,

Eui Young Kim,

Won Gu Kim,

Tae Yong Kim,

JinSook Ryu,

Dae Hyuk Moon,

TaeYon Sung,

Jong Ho Yoon,

Seong Chul Kim,

Suck Joon Hong,

Young Kee Shong

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-1270

Subject(s) - medicine , radioactive iodine , context (archaeology) , thyroglobulin , papillary thyroid cancer , thyroid cancer , thyroidectomy , adjuvant , ablation , radioiodine therapy , thyroid , total thyroidectomy , surgery , cancer , paleontology , biology

Some patients have elevated stimulated thyroglobulin (sTg) concentrations after reoperation for locoregionally recurrent/persistent papillary thyroid cancer (PTC). Little is known, however, about the efficacy of adjuvant radioactive iodine (RAI) therapy in these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research